ENT Devices Market - 1-3 USERS:2022

Market Report Coverage :
Start Year : 2021 - Forecast Year : 2030 - Start Value : $14,728.5 Million in 2021 - Forecast Value : $25,127.7 Million by 2030 - CAGR % : 0.06%
Description :
Market Report Coverage - ENT DevicesMarket Segmentation• Procedure Type - Flexible Transoral and Transnasal Procedures (Diagnosis and Intervention), Turbinate Reduction and Endoscopic Polyp Removal, and Tympanostomies and Vent Tube Operations• End User - Hospitals, ENT Clinics, Ambulatory Centers, and Others• Product Type - Diagnostic Devices, Surgical Devices, Hearing Aids, Visualization Devices, Surgical Shavers and Debriders, and OthersRegional Segmentation• North America - U.S. and Canada• Europe - Germany, U.K., France, Italy, and Rest-of-Europe• Asia-Pacific - Japan, China, India, Australia, and Rest-of-Asia-Pacific• Rest-of-the-World - Latin America and Middle East and AfricaMarket Growth Drivers• Growing Prevalence of Hearing Disorders• Growing Technology Integration in ENT Devices• Growing Preference for Minimally Invasive Procedures in ENT SpecialtyMarket Challenges• High Cost of ENT Procedures• Social Stigma Associated with Hearing DisordersMarket Opportunities• Emergence of Regional ENT Device Manufacturers• Synergies Between Local Healthcare Authorities and Key Medical Device CompaniesKey Companies ProfiledAmbu A/S, Atos Medical Ab, Boston Scientific Corporation, Cochlear Limited, Demant A/S, Eckert & Ziegler BEBIG AG, HOYA Corporation, Johnson & Johnson, KARL STORZ SE & Co. KG, Medtronic plc, Olympus Corporation, Richard Wolf GmbH, Smith & Nephew Plc, Sonova Holding AG, Stryker CorporationHow This Report Can Add ValueAssuming that the readers are the manufacturers of ENT devices market, they will be able to do the following:• Understand their position compared to some of the key players in the market• Stay updated with novel technology integration, features, and the latest developments in the market• Understand the impact of COVID-19 on the adoption of ENT devices and the entry barriers because of it• Gain insights into end-user perception with respect to the adoption of ENT• Identify some of the key players in the market and understand their valuable contributionKey Questions Answered in the Global ENT Devices Market Report• What are the key trends that have a strong influence on the global ENT devices market? How did the COVID-19 pandemic impact the growth of the ENT devices market?• What are the key development strategies which are implemented by the key players to maintain and capture market share? • How does the patent landscape of ENT devices look like?• What are the major market drivers, challenges, and opportunities in the global ENT devices market?• Which leading companies are dominating the global ENT devices market?• What are the regulations about the global ENT devices market? • What was the market value of the leading segments and sub-segments of the global ENT devices market? • How is each segment of the global ENT devices market expected to grow during the forecast period, and what is the expected revenue to be generated by each of the segment by the end of 2030?• Which region carries the potential for the significant expansion of key companies for the ENT devices market?Global ENT Devices Market Industry OverviewENT devices are used for diagnosing and treating various disorders of the ear, nose, and throat. The devices can be classified into diagnostic devices, surgical devices, visualization devices, hearing aids, surgical shavers and debriders, and others.The global ENT devices market is witnessing a high degree of technology integration over the past years. The market comprises various key medical device companies and local companies. The major factors that have a positive impact on the market’s growth include the growing prevalence of hearing disorders, growing technology integration in ENT devices, and growing preference for minimally invasive procedures in ENT specialty.During COVID-19, the growth of the ENT devices market was negatively impacted, especially in 2020. Although the market recovered quickly in the last quarter of 2020 and the telehealth integration in ENT specialty was a positive impact of COVID-19 on the market.The global ENT devices market report highlights that the market was valued at $13,799.5 million in 2020 and is expected to reach $25,127.7 million by the end of 2030. The market is expected to grow at a CAGR of 6.12% during the forecast period from 2021 to 2030.Global ENT Devices Market DriversThe factors driving the growth of the market include the growing prevalence of hearing disorders, growing technology integration in ENT devices, and growing preference for minimally invasive procedures in the ENT specialty. The growing prevalence of hearing disorders is the major driver for the market in established and emerging economies. For instance, according to a study published in The Lancet in March 2021, titled, ‘Hearing Loss Prevalence and Years Lived with Disability, 1990–2019: Findings from The Global Burden of Disease Study 2019’, approximately 1.5 billion people suffered from hearing disability globally in 2019. This infers that one in every five people suffered from a form of hearing disability globally. Furthermore, hearing disability is the third common factor for years lived with disability (YLDs) in the global population. The prevalence of hearing loss is projected to grow over the coming decade. According to World Health Organization (WHO), the number of people suffering from disabling hearing loss (DHL) can grow up to 630 million in 2030 and over 900 million by 2050.Consequently, the rising prevalence of hearing disorders will propel the adoption of hearing aid treatments and advance the growth of the global ENT devices market.Global ENT Devices Market ChallengesThe factors restraining the growth of the global ENT devices market include the high cost of the ENT procedures and the social stigma associated with hearing disorders. The high cost has limited the procedure volume in emerging as well as developed economies. For instance, according to a study published in NCBI in 2018, titled, ‘Health Care Costs and Cost-Effectiveness in Laryngotracheal Stenosis’, treatment of laryngotracheal stenosis (LTS) is one of the expensive ENT procedures. The mean annual cost associated with the disease was $4,080.09. Furthermore, according to another study titled, ‘Comparison of the Financial Burden of Survivors of Head and Neck Cancer with Other Cancer Survivors’, which was published in March 2019, patients getting treatment for head and neck cancer bear higher expenses as compared to other cancer patients. Also, these patients bear higher out-of-pocket costs. Thus, the high cost of the procedures and lack of reimbursement harm the growth of the global ENT devices market.Global ENT Devices Market OpportunitiesEmerging of regional ENT devices manufacturers and synergies between local healthcare authorities and key medical device companies are the major opportunities in the global ENT devices market. The key companies operating in the market can expand in emerging economies by partnering with local healthcare authorities. Such synergies will enable the companies to penetrate the markets effectively and expand their customer base. For instance, Cochlear Limited partnered with The Royal Victorian Eye and Ear Hospital in the U.K. for the development of Geelong Cochlear Care Centre. The center is the first care center of Cochlear Limited in the U.K. and is projected to improve the company’s presence in the country.Impact of COVID-19 on the Global ENT Devices MarketDuring COVID-19, the growth of the ENT devices market was negatively impacted, especially in 2020. Although the ENT facilities continued to operate, the sales of the companies were negatively impacted. Nonetheless, the market grew minimally in 2020 and is projected to witness considerable growth during the forecast period 2021-2030. The increasing technological innovations in the global market and growing adoption in emerging economies are the factors for the growth of the market.Market SegmentationGlobal ENT Devices Market (by Procedure)The global ENT devices market, on the basis of procedure, has been segmented into flexible transoral and transnasal procedures, turbinate reduction and polyp removal, and tympanostomies and vent tube operations.The flexible transoral and transnasal procedures accounted for the highest share of the market, which can be attributed to advancements in ENT devices. Global ENT Devices Market (by End User)The global ENT devices market, on the basis of end users, has been segmented into hospitals, ambulatory centers, ENT clinics, and others.Hospitals are at the forefront in terms of ENT devices adoption. The increasing focus on evidence-based care has been one of the strongest drivers for the adoption of ENT.The growing prominence for outpatient surgeries and rising establishments of ambulatory centers are the leading factors promoting the market's growth for the global ENT devices. The adoption of ENT devices in ambulatory surgical centers can be boosted by prioritizing the increasing demand for minimally invasive surgeries. Global ENT Devices Market (by Product Type)The global ENT devices market, on the basis of product type, has been segmented into diagnostic devices, surgical devices, hearing aids, visualization devices, surgical shavers and debriders, and others.Hearing aids is the largest product segment in the market, and the trend is projected to continue during the forecast period 2021-2030. Furthermore, surgical devices is projected to be the fastest-growing segment owing to the growing technological advancements in the ENT specialty.Global ENT Devices Market (by Region)The different regions covered under the global ENT devices market include North America, Europe, Asia-Pacific, and Rest-of-the-World.North America dominates the global ENT devices market due to the high prevalence of hearing disorders, growing geriatric population, and high reimbursement rates. The Asia-Pacific ENT devices market is one of the lucrative markets with immense potential for expansion by key players of the global ENT market. The Asia-Pacific ENT devices market is expected to grow at the fastest rate in the forecast period, and this can be attributed to the massive geriatric population base, driving the demand for minimally invasive and non-invasive surgical procedures.Key Market Players and Competition SynopsisSome of the key players operating in the market include Ambu A/S, Atos Medical Ab, Boston Scientific Corporation, Cochlear Limited, Demant A/S, Eckert & Ziegler AG, HOYA Corporation, Johnson & Johnson, KARL STORZ SE & Co. KG, Medtronic plc, Olympus Corporation, Richard Wolf GmbH, Smith & Nephew Plc, Sonova Holding AG, and Stryker Corporation.Some of the strategies covered in this segment are funding activities, mergers and acquisitions (M&As), partnerships, alliances, and business expansion, regulatory and legal activities, and new offerings. The preferred strategy for companies has been launches of new products or new offerings followed by partnerships, alliances, and business expansion.
Countries Covered :
North America U.S. CanadaEurope Germany Italy France U.K. Rest-of-EuropeAsia-Pacific China India Japan Australia Rest-of-Asia-PacificRest-of-the-World Latin America Middle East and Africa
Keywords :
Ear, Nose, and Throat Market, ENT Devices Market, ENT Devices Industry, ENT Devices Report, ENT Devices Market Forecasts, ENT Devices Market Trends, ENT Devices Market Companies, ENT Devices Market Analysis, ENT Devices Industry Analysis, What is ENT Devices, ENT Devices Definition, ENT Devices Market Competitive Landscape, ENT Devices Market Drivers, ENT Devices Market Segments, ENT Devices Market Outlook, ENT Devices Market Opportunity, ENT Devices Market Growth, ENT Devices Market Share, ENT Devices Market Size, North America ENT Devices Market, Europe ENT Devices Market, Asia-Pacific ENT Devices Market
Press Release :
The global ENT devices market is projected to reach $25,127.7 million by 2030, reveals the premium market intelligence study by BIS Research. The study also highlights that the market is set to witness a CAGR of 6.12% during the forecast period 2021-2030.The comprehensive study of the global ENT devices market by BIS Research extensively covers the following:• Market numbers on the procedure type, product type, and end-user segments that are influencing the market• More than 30 key ENT devices companies offering ENT devices present in the market• Market share analysis for global ENT devices companies• Detailed global and regional market analysis, including the scrutiny of 14 key countries• Country-wise analysis and forecast for various product types and end users• Impact on the adoption of ENT devices due to the COVID-19 pandemicTo emphasize the potential of ENT devices, Swati Sood, Lead Analyst– BIS Research, states, “The pandemic had moderate-low impact on the global ENT devices market. During the lockdown period in 2020, the companies witnessed a considerable decline in their revenue as the non-elective procedures, and routine appointments were ceased. Nonetheless, as the global lockdown was lifted and the surgeries resumed, the market grew considerably. Furthermore, the high adoption of telehealth in ENT specialty was also a major impact of the pandemic on the global ENT devices market.Key Companies Operating in the MarketSome of the key players operating in the market include Ambu A/S, Atos Medical Ab, Boston Scientific Corporation, Cochlear Limited, Demant A/S, Eckert & Ziegler AG, HOYA Corporation, Johnson & Johnson, KARL STORZ SE & Co. KG, Medtronic plc, Olympus Corporation, Richard Wolf GmbH, Smith & Nephew Plc, Sonova Holding AG, and Stryker CorporationWho should buy this report?Assuming that the reader is a manufacturer of ENT devices, they will be able to do the following:• Understand their position as compared to some of the key players in the market• Stay updated with novel technology integration, features, and the latest developments in the market• Understand the impact of COVID-19 on the adoption of ENT devices and the entry barriers as a result of it• Identify some of the key players in the market and understand their valuable contributionHow can market intelligence on the global ENT devices market add value to an organization’s decision-making process?The report can benefit in the following ways:• Aid in product development• Aid in understanding the regulatory scenario of the market in different regions• Aid in understanding the patent trend of the market• Aid in targeting a segment for launching a new product• Aid in understanding the growth potential of different products• Support in analyzing the market opportunities• Provide competitive benchmarking of the key companiesKey Questions Answered• What are the key trends that have a strong influence on the global ENT devices market? How did the COVID-19 pandemic impact the growth of the ENT devices market?• What are the key development strategies which are implemented by the key players to maintain and capture market share? • How does the patent landscape of ENT devices look like?• What are the major market drivers, challenges, and opportunities in the global ENT devices market?• Which leading companies are dominating the global ENT devices market?• What are the regulations about the global ENT devices market? What are the initiatives implemented by different government bodies to reduce the cancer rate?• What was the market value of the leading segments and sub-segments of the global ENT devices market? • How is each segment of the global ENT devices market expected to grow during the forecast period, and what is the expected revenue to be generated by each of the segments by the end of 2030?• Which region carries the potential for the significant expansion of key companies for the ENT devices market?
Companies Mentioned :
Ambu A/SAtos Medical AbBoston Scientific CorporationCochlear LimitedDemant A/SEckert & Ziegler BEBIG AGHOYA CorporationJohnson & JohnsonKARL STORZ SE & Co. KGMedtronic plcOlympus CorporationRichard Wolf GmbHSmith & Nephew PlcSonova Holding AGStryker Corporation
Press Release :
The global ENT devices market is projected to reach $25,127.7 million by 2030, reveals the premium market intelligence study by BIS Research. The study also highlights that the market is set to witness a CAGR of 6.12% during the forecast period 2021-2030.The comprehensive study of the global ENT devices market by BIS Research extensively covers the following:• Market numbers on the procedure type, product type, and end-user segments that are influencing the market• More than 30 key ENT devices companies offering ENT devices present in the market• Market share analysis for global ENT devices companies• Detailed global and regional market analysis, including the scrutiny of 14 key countries• Country-wise analysis and forecast for various product types and end users• Impact on the adoption of ENT devices due to the COVID-19 pandemicTo emphasize the potential of ENT devices, Swati Sood, Lead Analyst– BIS Research, states, “The pandemic had moderate-low impact on the global ENT devices market. During the lockdown period in 2020, the companies witnessed a considerable decline in their revenue as the non-elective procedures, and routine appointments were ceased. Nonetheless, as the global lockdown was lifted and the surgeries resumed, the market grew considerably. Furthermore, the high adoption of telehealth in ENT specialty was also a major impact of the pandemic on the global ENT devices market.Key Companies Operating in the MarketSome of the key players operating in the market include Ambu A/S, Atos Medical Ab, Boston Scientific Corporation, Cochlear Limited, Demant A/S, Eckert & Ziegler AG, HOYA Corporation, Johnson & Johnson, KARL STORZ SE & Co. KG, Medtronic plc, Olympus Corporation, Richard Wolf GmbH, Smith & Nephew Plc, Sonova Holding AG, and Stryker CorporationWho should buy this report?Assuming that the reader is a manufacturer of ENT devices, they will be able to do the following:• Understand their position as compared to some of the key players in the market• Stay updated with novel technology integration, features, and the latest developments in the market• Understand the impact of COVID-19 on the adoption of ENT devices and the entry barriers as a result of it• Identify some of the key players in the market and understand their valuable contributionHow can market intelligence on the global ENT devices market add value to an organization’s decision-making process?The report can benefit in the following ways:• Aid in product development• Aid in understanding the regulatory scenario of the market in different regions• Aid in understanding the patent trend of the market• Aid in targeting a segment for launching a new product• Aid in understanding the growth potential of different products• Support in analyzing the market opportunities• Provide competitive benchmarking of the key companiesKey Questions Answered• What are the key trends that have a strong influence on the global ENT devices market? How did the COVID-19 pandemic impact the growth of the ENT devices market?• What are the key development strategies which are implemented by the key players to maintain and capture market share? • How does the patent landscape of ENT devices look like?• What are the major market drivers, challenges, and opportunities in the global ENT devices market?• Which leading companies are dominating the global ENT devices market?• What are the regulations about the global ENT devices market? What are the initiatives implemented by different government bodies to reduce the cancer rate?• What was the market value of the leading segments and sub-segments of the global ENT devices market? • How is each segment of the global ENT devices market expected to grow during the forecast period, and what is the expected revenue to be generated by each of the segments by the end of 2030?• Which region carries the potential for the significant expansion of key companies for the ENT devices market?
Headline :
Global ENT Devices Market to Reach $25,127.7 Million by 2030
Table of Contents :
1 Market1.1 Global Market Outlook1.1.1 Product Definition1.1.2 Inclusion and Exclusion Criteria1.1.3 Key Findings1.1.4 Assumptions and Limitations1.1.5 Global Market Scenario1.1.5.1 Realistic Scenario1.1.5.2 Optimistic Scenario1.1.5.3 Pessimistic Scenario1.2 Industry Outlook1.2.1 Technology Landscape1.2.1.1 Key Trends1.2.1.2 Opportunity Assessment1.2.1.2.1 Short-Term Potential1.2.1.2.2 Long-Term Potential1.2.2 Patent Analysis1.2.2.1 Patent Publication Growth Trend1.2.2.2 Patent Analysis by Country/Cluster1.2.3 Product Benchmarking1.2.4 Ongoing Clinical Trial Studies1.3 Impact of COVID-19 on Global ENT Devices Market1.3.1 Impact on Facilities1.3.2 Impact on Device Adoption1.3.3 Impact on Market Size1.3.3.1 Pre-COVID-19 Phase1.3.3.2 During COVID-19 Phase1.3.3.3 Post-COVID-19 Phase1.4 Procedure Volume1.5 Market Analysis1.5.1 Exoscopes Market1.5.1.1 Market Size and Forecast1.5.1.2 By Region1.5.1.3 By Application1.5.1.4 By ENT Procedures1.5.2 Comparative Analysis1.5.2.1 Headlight Market Vs. Surgical Loop Market1.5.2.2 Endoscopic Ear Surgeries Vs. Open Surgeries1.5.2.2.1 Procedure Volume1.5.2.2.2 Market Size1.6 Business Dynamics1.6.1 Impact Analysis1.6.2 Business Drivers1.6.2.1 Growing Prevalence of Hearing Disorders1.6.2.2 Growing Technology Integration in ENT Devices1.6.2.3 Growing Preference for Minimally Invasive Procedures in ENT Specialty1.6.3 Business Restraints1.6.3.1 High Cost of ENT Procedures1.6.3.2 Social Stigma Associated with Hearing Disorders1.6.4 Business Opportunities1.6.4.1 Emergence of Regional ENT Device Manufacturers1.6.4.2 Synergies Between Local Healthcare Authorities and Key Medical Device Companies2 Application2.1 Global ENT Devices Market (by Procedure)2.1.1 Flexible Transoral and Transnasal Procedures2.1.1.1 Diagnosis2.1.1.1.1 Procedure Volume2.1.1.1.1.1 Transnasal Laryngeal Biopsies2.1.1.1.1.2 Transnasal Injections for Vocal Cords2.1.1.1.1.3 Transoral Flexible Diagnostic Endoscopy2.1.1.1.2 Market Size and Forecast2.1.1.1.2.1 Single-Use Video Endoscopes2.1.1.1.2.2 Others2.1.1.2 Intervention2.1.1.2.1 Procedure Volume2.1.1.2.1.1 Therapeutic Endoscopy of Larynx2.1.1.2.2 Market Size and Forecast2.1.1.2.2.1 Single-Use Video Endoscopes2.1.1.2.2.2 Others2.1.2 Turbinate Reduction and Endoscopic Polyp Removal2.1.2.1 Procedure Volume2.1.2.1.1 Turbinate Reduction2.1.2.1.2 Endoscopic Polyp Removal2.1.2.2 Market Size2.1.2.2.1 Turbinate Reduction2.1.2.2.2 Endoscopic Polyp Removal2.1.3 Tympanostomies and Vent Tube Operations2.1.3.1 Procedure Volume2.1.3.2 Market Size (by Country)2.2 Global ENT Devices Market (by End User)2.2.1 Opportunity Assessment2.2.2 Growth-Share Matrix2.2.2.1 Global ENT Surgical Devices Market, Growth-Share Matrix (by End User)2.2.2.2 Global ENT Diagnostic Devices Market, Growth Share Matrix (by End Users)2.2.3 Hospitals2.2.4 ENT Clinics2.2.5 Ambulatory Centers2.2.6 Others3 Products3.1 Global ENT Devices Market (by Product Type)3.1.1 Opportunity Assessment3.1.2 Growth Share Matrix3.1.3 Diagnostic Devices3.1.4 Surgical Devices3.1.5 Hearing Aids3.1.6 Visualization Devices3.1.6.1 By Region3.1.7 Surgical Shavers and Debriders3.1.7.1 By Region3.1.8 Others4 Regions4.1 North America ENT Devices Market4.1.1 Regulatory Framework4.1.2 Market4.1.2.1 Key Findings and Opportunity Assessment4.1.2.2 Business Drivers4.1.2.3 Business Restraints4.1.2.4 Impact Analysis4.1.2.5 Sizing and Forecast4.1.3 Application4.1.3.1 North America ENT Surgical Devices Market (by End User)4.1.3.2 North America ENT Diagnostic Devices Market (by End User)4.1.4 Product4.1.4.1 North America ENT Devices Market (by Product Type)4.1.5 North America ENT Devices Market (by Country)4.1.5.1 U.S.4.1.5.1.1 Market4.1.5.1.1.1 Business Restraints4.1.5.1.1.2 Business Drivers4.1.5.1.1.3 Sizing and Forecast Analysis4.1.5.1.2 Application4.1.5.1.2.1 U.S. ENT Surgical Devices Market (by End User)4.1.5.1.2.2 U.S. ENT Diagnostic Devices Market (by End User)4.1.5.1.3 Product4.1.5.1.3.1 U.S. ENT Devices Market (by Product Type)4.1.5.2 Canada4.1.5.2.1 Market4.1.5.2.1.1 Business Restraints4.1.5.2.1.2 Business Drivers4.1.5.2.1.3 Sizing and Forecast Analysis4.1.5.2.2 Application4.1.5.2.2.1 Canada ENT Surgical Devices Market (by End User)4.1.5.2.2.2 Canada ENT Diagnostic Devices Market (by End User)4.1.5.2.3 Product4.1.5.2.3.1 Canada ENT Devices Market (by Product Type)4.2 Europe ENT Devices Market4.2.1 Regulatory Framework4.2.2 Market4.2.2.1 Key Findings and Opportunity Assessment4.2.2.2 Business Drivers4.2.2.3 Business Restraints4.2.2.4 Impact Analysis4.2.2.5 Sizing and Forecast4.2.3 Application4.2.3.1 Europe ENT Surgical Devices Market (by End User)4.2.3.2 Europe ENT Diagnostic Devices Market (by End User)4.2.4 Product4.2.4.1 Europe ENT Devices Market (by Product Type)4.2.5 Europe ENT Devices Market (by Country)4.2.5.1 Germany4.2.5.1.1 Market4.2.5.1.1.1 Business Restraints4.2.5.1.1.2 Business Drivers4.2.5.1.1.3 Sizing and Forecast Analysis4.2.5.1.2 Application4.2.5.1.2.1 Germany ENT Surgical Devices Market (by End User)4.2.5.1.2.2 Germany ENT Diagnostic Devices Market (by End User)4.2.5.1.3 Product4.2.5.1.3.1 Germany ENT Devices Market (by Product Type)4.2.5.2 U.K.4.2.5.2.1 Market4.2.5.2.1.1 Business Restraints4.2.5.2.1.2 Business Drivers4.2.5.2.1.3 Sizing and Forecast Analysis4.2.5.2.2 Application4.2.5.2.2.1 U.K. ENT Surgical Devices Market (by End User)4.2.5.2.2.2 U.K. ENT Diagnostic Devices Market (by End User)4.2.5.2.3 Product4.2.5.2.3.1 U.K. ENT Devices Market (by Product Type)4.2.5.3 France4.2.5.3.1 Market4.2.5.3.1.1 Business Restraints4.2.5.3.1.2 Business Drivers4.2.5.3.1.3 Sizing and Forecast Analysis4.2.5.3.2 Application4.2.5.3.2.1 France ENT Surgical Devices Market (by End User)4.2.5.3.2.2 France ENT Diagnostic Devices Market (by End User)4.2.5.3.3 Product4.2.5.3.3.1 France ENT Devices Market (by Product Type)4.2.5.4 Italy4.2.5.4.1 Market4.2.5.4.1.1 Business Restraints4.2.5.4.1.2 Business Drivers4.2.5.4.1.3 Sizing and Forecast Analysis4.2.5.4.2 Application4.2.5.4.2.1 Italy ENT Surgical Devices Market (by End User)4.2.5.4.2.2 Italy ENT Diagnostic Devices Market (by End User)4.2.5.4.3 Product4.2.5.4.3.1 Italy ENT Devices Market (by Product Type)4.2.5.5 Rest-of-Europe4.2.5.5.1 Market4.2.5.5.1.1 Business Restraints4.2.5.5.1.2 Business Drivers4.2.5.5.1.3 Sizing and Forecast Analysis4.2.5.5.2 Application4.2.5.5.2.1 Rest-of-Europe ENT Surgical Devices Market (by End User)4.2.5.5.2.2 Rest-of-Europe ENT Diagnostic Devices Market (by End User)4.2.5.5.3 Product4.2.5.5.3.1 Rest-of-Europe ENT Devices Market (by Product Type)4.3 Asia-Pacific ENT Devices Market4.3.1 Regulatory Framework4.3.2 Market4.3.2.1 Key Findings and Opportunity Assessment4.3.2.2 Business Drivers4.3.2.3 Business Restraints4.3.2.4 Impact Analysis4.3.2.5 Sizing and Forecast4.3.3 Application4.3.3.1 Asia-Pacific ENT Surgical Devices Market (by End User)4.3.3.2 Asia-Pacific ENT Diagnostic Devices Market (by End User)4.3.4 Product4.3.4.1 Asia-Pacific ENT Devices Market (by Product Type)4.3.5 Asia-Pacific ENT Devices Market (by Country)4.3.5.1 China4.3.5.1.1 Market4.3.5.1.1.1 Business Restraints4.3.5.1.1.2 Business Drivers4.3.5.1.1.3 Sizing and Forecast Analysis4.3.5.1.2 Application4.3.5.1.2.1 China ENT Surgical Devices Market (by End User)4.3.5.1.2.2 China ENT Diagnostic Devices Market (by End User)4.3.5.1.3 Product4.3.5.1.3.1 China ENT Devices Market (by Product Type)4.3.5.2 Japan4.3.5.2.1 Market4.3.5.2.1.1 Business Restraints4.3.5.2.1.2 Business Drivers4.3.5.2.1.3 Sizing and Forecast Analysis4.3.5.2.2 Application4.3.5.2.2.1 Japan ENT Surgical Devices Market (by End User)4.3.5.2.2.2 Japan ENT Diagnostic Devices Market (by End User)4.3.5.2.3 Product4.3.5.2.3.1 Japan ENT Devices Market (by Product Type)4.3.5.3 India4.3.5.3.1 Market4.3.5.3.1.1 Business Restraints4.3.5.3.1.2 Business Drivers4.3.5.3.1.3 Sizing and Forecast Analysis4.3.5.3.2 Application4.3.5.3.2.1 India ENT Surgical Devices Market (by End User)4.3.5.3.2.2 India ENT Diagnostic Devices Market (by End User)4.3.5.3.3 Product4.3.5.3.3.1 India ENT Devices Market (by Product Type)4.3.5.4 Australia4.3.5.4.1 Market4.3.5.4.1.1 Business Restraints4.3.5.4.1.2 Business Drivers4.3.5.4.1.3 Sizing and Forecast Analysis4.3.5.4.2 Application4.3.5.4.2.1 Australia ENT Surgical Devices Market (by End User)4.3.5.4.2.2 Australia ENT Diagnostic Devices Market (by End User)4.3.5.4.3 Product4.3.5.4.3.1 Australia ENT Devices Market (by Product Type)4.3.5.5 Rest-of-Asia-Pacific4.3.5.5.1 Market4.3.5.5.1.1 Business Restraints4.3.5.5.1.2 Business Drivers4.3.5.5.1.3 Sizing and Forecast Analysis4.3.5.5.2 Application4.3.5.5.2.1 Rest-of-Asia-Pacific ENT Surgical Devices Market (by End User)4.3.5.5.2.2 Rest-of-Asia-Pacific ENT Diagnostic Devices Market (by End User)4.3.5.5.3 Product4.3.5.5.3.1 Rest-of-Asia-Pacific ENT Devices Market (by Product Type)4.4 Rest-of-the-World ENT Devices Market4.4.1 Regulatory Framework4.4.2 Market4.4.2.1 Key Findings and Opportunity Assessment4.4.2.2 Business Drivers4.4.2.3 Business Restraints4.4.2.4 Impact Analysis4.4.2.5 Sizing and Forecast4.4.3 Application4.4.3.1 Rest-of-the-World ENT Surgical Devices Market (by End User)4.4.3.2 Rest-of-the-World ENT Diagnostic Devices Market (by End User)4.4.4 Product4.4.4.1 Rest-of-the-World ENT Devices Market (by Product Type)4.4.5 Rest-of-the-World ENT Devices Market (by Region)4.4.5.1 Latin America4.4.5.1.1 Market4.4.5.1.1.1 Business Restraints4.4.5.1.1.2 Business Drivers4.4.5.1.1.3 Sizing and Forecast Analysis4.4.5.1.2 Application4.4.5.1.2.1 Latin America ENT Surgical Devices Market (by End User)4.4.5.1.2.2 Latin America ENT Diagnostic Devices Market (by End User)4.4.5.1.3 Product4.4.5.1.3.1 Latin America ENT Devices Market (by Product Type)4.4.5.2 Middle East and Africa4.4.5.2.1 Market4.4.5.2.1.1 Business Restraints4.4.5.2.1.2 Business Drivers4.4.5.2.1.3 Sizing and Forecast Analysis4.4.5.2.2 Application4.4.5.2.2.1 Middle East and Africa ENT Surgical Devices Market (by End User)4.4.5.2.2.2 Middle East and Africa ENT Diagnostic Devices Market (by End User)4.4.5.2.3 Product4.4.5.2.3.1 Middle East and Africa ENT Devices Market (by Product Type)5 Markets - Competitive Benchmarking & Company Profiles5.1 Competitive Benchmarking and Company Profiles5.1.1 Competitive Landscape5.1.1.1 Key Strategies and Developments5.1.1.1.1 New Offerings5.1.1.1.2 Partnerships, Alliances, and Business Expansion5.1.1.1.3 Regulatory and Legal5.1.1.1.4 Mergers and Acquisitions5.1.1.1.5 Funding5.2 Company Profiles5.2.1 Ambu A/S5.2.1.1 Company Overview5.2.1.2 Role of Ambu A/S in Global ENT Devices Market5.2.1.3 Financials5.2.1.4 Recent Developments5.2.1.5 SWOT Analysis5.2.2 Atos Medical Ab5.2.2.1 Company Overview5.2.2.2 Role of Atos Medical Ab in the Global ENT Devices Market5.2.2.3 Financials5.2.2.4 Recent Developments5.2.2.5 SWOT Analysis5.2.3 Boston Scientific Corporation5.2.3.1 Company Overview5.2.3.2 Role of Boston Scientific Corporation in the Global ENT Devices Market5.2.3.3 Financials5.2.3.4 Recent Developments5.2.3.5 SWOT Analysis5.2.4 Cochlear Limited5.2.4.1 Company Overview5.2.4.2 Role of Cochlear Limited in the Global ENT Devices Market5.2.4.3 Financials5.2.4.4 Recent Developments5.2.4.5 SWOT Analysis5.2.5 Demant A/S5.2.5.1 Company Overview5.2.5.2 Role of Demant A/S in Global ENT Devices Market5.2.5.3 Financials5.2.5.4 Recent Developments5.2.5.5 SWOT Analysis5.2.6 Eckert & Ziegler BEBIG AG5.2.6.1 Company Overview5.2.6.2 Role of Eckert & Ziegler BEBIG AG in the Global ENT Devices Market5.2.6.3 Financials5.2.6.4 Recent Developments5.2.6.5 SWOT Analysis5.2.7 HOYA Corporation5.2.7.1 Company Overview5.2.7.2 Role of HOYA Corporation in Global ENT Devices Market5.2.7.3 Financials5.2.7.4 Recent Developments5.2.7.5 SWOT Analysis5.2.8 Johnson & Johnson5.2.8.1 Company Overview5.2.8.2 Role of Johnson & Johnson in the Global ENT Devices Market5.2.8.3 Financials5.2.8.4 Recent Developments5.2.8.5 SWOT Analysis5.2.9 KARL STORZ SE & Co. KG5.2.9.1 Company Overview5.2.9.2 Role of KARL STORZ SE & Co. KG in Global ENT Devices Market5.2.9.3 Recent Developments5.2.9.4 SWOT Analysis5.2.10 Medtronic plc5.2.10.1 Company Overview5.2.10.2 Role of Medtronic plc in the Global ENT Devices Market5.2.10.3 Financials5.2.10.4 Recent Developments5.2.10.5 SWOT Analysis5.2.11 Olympus Corporation5.2.11.1 Company Overview5.2.11.2 Role of Olympus Corporation in Global ENT Devices Market5.2.11.3 Financials5.2.11.4 Recent Developments5.2.11.5 SWOT Analysis5.2.12 Richard Wolf GmbH5.2.12.1 Company Overview5.2.12.2 Role of Richard Wolf GmbH in Global ENT Devices Market5.2.12.3 SWOT Analysis5.2.13 Smith & Nephew Plc5.2.13.1 Company Overview5.2.13.2 Role of Smith & Nephew Plc in Global ENT Devices Market5.2.13.3 Financials5.2.13.4 Recent Developments5.2.13.5 SWOT Analysis5.2.14 Sonova Holding AG5.2.14.1 Company Overview5.2.14.2 Role of Sonova Holding AG in Global ENT Devices Market5.2.14.3 Financials5.2.14.4 Recent Developments5.2.14.5 SWOT Analysis5.2.15 Stryker Corporation5.2.15.1 Company Overview5.2.15.2 Role of Stryker Corporation in Global ENT Devices Market5.2.15.3 Financials5.2.15.4 Recent Developments5.2.15.5 SWOT Analysis6 Research Methodology6.1 Data Collection and Analysis6.2 Data Sources6.2.1 Primary Sources6.2.2 Secondary Sources6.3 Data Triangulation6.4 Market Estimation6.5 Assumptions and LimitationsList of Figures Figure 1: Global ENT Devices Market, $Million, 2020-2030Figure 2: Global ENT Devices Market, Industry AnalysisFigure 3: Global ENT Devices Market, Key Developments, January 2018-15th November 2021Figure 4: Global ENT Devices Market Share Analysis (by Product), 2020 Vs. 2030Figure 5: Global ENT Devices Market (by Region), 2020 and 2030Figure 6: Global ENT Devices Market, Realistic Growth Scenario, $Million, 2020-2030Figure 7: Global ENT Devices Market, Optimistic Growth Scenario, $Million, 2020-2030Figure 8: Global ENT Devices Market, Pessimistic Growth Scenario, $Million, 2020-2030Figure 9: Global ENT Devices Market, Short-Term Potential, $Million, 2020-2025Figure 10: Global ENT Devices Market, Long-Term Growth, $Million, 2025-2030Figure 11: Global ENT Devices Market, Patent Filing Trend (by Year), 2016-2021Figure 12: Global ENT Devices Market, Patent Filing Trend (by Country/Cluster), 2016-2021Figure 13: Global Exoscopes Market, $Million, 2020-2030Figure 14: Global Exoscopes Market (by Region), $Million, 2020-2030Figure 15: Global Exoscopes Market (by Application), $Million, 2020-2030Figure 16: Global ENT Exoscopes Market (by Application), $Million, 2020-2030Figure 17: Global Endoscopic and Visualization Market, $Million, 2020-2030Figure 18: Global Prevalence of Hearing Loss, 2015-2019Figure 19: Prevalence of Disabling Hearing Loss, 2018Figure 20: Global ENT Devices Market, by ProcedureFigure 21: Diagnostic Endoscopy of Larynx Procedure Volume, 2019-2020Figure 22: Transnasal Laryngeal Biopsies Procedure Volume, 2019-2020Figure 23: Transnasal Injections for Vocal Cords Procedure Volume, 2019-2020Figure 24: Transnasal Flexible Diagnostic Endoscopy Procedure Volume, 2019-2020Figure 25: Global ENT Diagnostic Devices Market (Single-Use Video Endoscopes), $Million, 2020-2030Figure 26: Global ENT Diagnostic Devices Market (by Others), $Million, 2020-2030Figure 27: Therapeutic Endoscopy of Larynx Procedure Volume, 2019-2020Figure 28: Global ENT Intervention Devices Market (Single-Use Video Endoscopes), $Million, 2020-2030Figure 29: Global ENT Intervention Devices Market (by Others), $Million, 2020-2030Figure 30: Turbinate Reduction Procedure Volume, 2019-2020Figure 31: Endoscopic Polyp Removal Procedure Volume, 2019-2020Figure 32: Global Turbinate Reduction Market, $Million, 2019-2020Figure 33: Global Endoscopic Polyp Removal Market, $Million, 2019-2020Figure 34: Tympanostomies and Vent Tube Operations Procedure Volume, 2019-2020Figure 35: Tympanostomies and Vent Tube Operations Market, $Million, 2019-2020Figure 36: Global ENT Devices Market (by End User)Figure 37: Global ENT Surgical Devices Market, Growth Share Matrix (by End User), 2020-2030Figure 38: Global ENT Diagnostic Devices Market, Growth Share Matrix (by End User), 2020-2030Figure 39: Global ENT Surgical Devices Market (by Hospitals), $Million, 2020-2030Figure 40: Global ENT Diagnostic Devices Market (by Hospitals), $Million, 2020-2030Figure 41: Global ENT Surgical Devices Market (by ENT Clinics), $Million, 2020-2030Figure 42: Global ENT Diagnostic Devices Market (by ENT Clinics), $Million, 2020-2030Figure 43: Global ENT Surgical Devices Market (by Ambulatory Centers), $Million, 2020-2030Figure 44: Global ENT Diagnostic Devices Market (by Ambulatory Centers), $Million, 2020-2030Figure 45: Global ENT Diagnostic Devices Market (by Others), $Million, 2020-2030Figure 46: Global ENT Devices Market Incremental Growth Opportunity (by Product Type), $Million, 2020-2030Figure 47: Global ENT Devices Market, Growth Share Matrix (by Product Type), 2020-2030Figure 48: Global ENT Devices Market (Diagnostic Devices), $Million, 2020-2030Figure 49: Global ENT Devices Market (Surgical Devices), $Million, 2020-2030Figure 50: Global ENT Devices Market (Hearing Aids), $Million, 2020-2030Figure 51: Global ENT Devices Market (Visualization Devices), $Million, 2020-2030Figure 52: Global ENT Visualization Devices Market (by Region), $Million, 2020-2030Figure 53: Global ENT Devices Market (Surgical Shavers and Debriders), $Million, 2020-2030Figure 54: Global ENT Surgical Shavers and Debriders Market (by Region), $Million, 2020-2030Figure 55: Global ENT Devices Market (by Others), $Million, 2020-2030Figure 56: Global ENT Devices Market (by Region), 2020 and 2030Figure 57: North America ENT Devices Market Incremental Growth Opportunity, $Million, 2020-2030Figure 58: North America ENT Devices Market, $Million, 2020-2030Figure 59: North America ENT Surgical Devices Market (by End User), $Million, 2020-2030Figure 60: North America ENT Diagnostic Devices Market (by End User), $Million, 2020-2030Figure 61: North America ENT Devices Market (by Product Type), $Million, 2020-2030Figure 62: U.S. ENT Devices Market, $Million, 2020-2030Figure 63: U.S. ENT Surgical Devices Market (by End User), $Million, 2020-2030Figure 64: U.S. ENT Diagnostic Devices Market (by End User), $Million, 2020-2030Figure 65: U.S. ENT Devices Market (by Product Type), $Million, 2020-2030Figure 66: Canada ENT Devices Market, $Million, 2020-2030Figure 67: Canada ENT Surgical Devices Market (by End User), $Million, 2020-2030Figure 68: Canada ENT Diagnostic Devices Market (by End User), $Million, 2020-2030Figure 69: Canada ENT Devices Market (by Product Type), $Million, 2020-2030Figure 70: Europe ENT Devices Market Incremental Growth Opportunity, $Million, 2020-2030Figure 71: Europe ENT Devices Market, $Million, 2020-2030Figure 72: Europe ENT Surgical Devices Market (by End User), $Million, 2020-2030Figure 73: Europe ENT Diagnostic Devices Market (by End User), $Million, 2020-2030Figure 74: Europe ENT Devices Market (by Product Type), $Million, 2020-2030Figure 75: Germany ENT Devices Market, $Million, 2020-2030Figure 76: Germany ENT Surgical Devices Market (by End User), $Million, 2020-2030Figure 77: Germany ENT Diagnostic Devices Market (by End User), $Million, 2020-2030Figure 78: Germany ENT Devices Market (by Product Type), $Million, 2020-2030Figure 79: U.K. ENT Devices Market, $Million, 2020-2030Figure 80: U.K. ENT Surgical Devices Market (by End User), $Million, 2020-2030Figure 81: U.K. ENT Diagnostic Devices Market (by End User), $Million, 2020-2030Figure 82: U.K. ENT Devices Market (by Product Type), $Million, 2020-2030Figure 83: France ENT Devices Market, $Million, 2020-2030Figure 84: France ENT Surgical Devices Market (by End User), $Million, 2020-2030Figure 85: France ENT Diagnostic Devices Market (by End User), $Million, 2020-2030Figure 86: France ENT Devices Market (by Product Type), $Million, 2020-2030Figure 87: Italy ENT Devices Market, $Million, 2020-2030Figure 88: Italy ENT Surgical Devices Market (by End User), $Million, 2020-2030Figure 89: Italy ENT Diagnostic Devices Market (by End User), $Million, 2020-2030Figure 90: Italy ENT Devices Market (by Product Type), $Million, 2020-2030Figure 91: Rest-of-Europe ENT Devices Market, $Million, 2020-2030Figure 92: Rest-of-Europe ENT Surgical Devices Market (by End User), $Million, 2020-2030Figure 93: Rest-of-Europe ENT Diagnostic Devices Market (by End User), $Million, 2020-2030Figure 94: Rest-of-Europe ENT Devices Market (by Product Type), $Million, 2020-2030Figure 95: Asia-Pacific ENT Devices Market Incremental Growth Opportunity, $Million, 2020-2030Figure 96: Asia-Pacific ENT Devices Market, $Million, 2020-2030Figure 97: Asia-Pacific ENT Surgical Devices Market (by End User), $Million, 2020-2030Figure 98: Asia-Pacific ENT Diagnostic Devices Market (by End User), $Million, 2020-2030Figure 99: Asia-Pacific ENT Devices Market (by Product Type), $Million, 2020-2030Figure 100: China ENT Devices Market, $Million, 2020-2030Figure 101: China ENT Surgical Devices Market (by End User), $Million, 2020-2030Figure 102: China ENT Diagnostic Devices Market (by End User), $Million, 2020-2030Figure 103: China ENT Devices Market (by Product Type), $Million, 2020-2030Figure 104: Japan ENT Devices Market, $Million, 2020-2030Figure 105: Japan ENT Surgical Devices Market (by End User), $Million, 2020-2030Figure 106: Japan ENT Diagnostic Devices Market (by End User), $Million, 2020-2030Figure 107: Japan ENT Devices Market (by Product Type), $Million, 2020-2030Figure 108: India ENT Devices Market, $Million, 2020-2030Figure 109: India ENT Surgical Devices Market (by End User), $Million, 2020-2030Figure 110: India ENT Diagnostic Devices Market (by End User), $Million, 2020-2030Figure 111: India ENT Devices Market (by Product Type), $Million, 2020-2030Figure 112: Australia ENT Devices Market, $Million, 2020-2030Figure 113: Australia ENT Surgical Devices Market (by End User), $Million, 2020-2030Figure 114: Australia ENT Diagnostic Devices Market (by End User), $Million, 2020-2030Figure 115: Australia ENT Devices Market (by Product Type), $Million, 2020-2030Figure 116: Rest-of-Asia-Pacific ENT Devices Market, $Million, 2020-2030Figure 117: Rest-of-Asia-Pacific ENT Surgical Devices Market (by End User), $Million, 2020-2030Figure 118: Rest-of-Asia-Pacific ENT Diagnostic Devices Market (by End User), $Million, 2020-2030Figure 119: Rest-of-Asia-Pacific ENT Devices Market (by Product Type), $Million, 2020-2030Figure 120: Rest-of-the-World ENT Devices Market Incremental Growth Opportunity, $Million, 2020-2030Figure 121: Rest-of-the-World ENT Devices Market, $Million, 2020-2030Figure 122: Rest-of-the-World ENT Surgical Devices Market (by End User), $Million, 2020-2030Figure 123: Rest-of-the-World ENT Diagnostic Devices Market (by End User), $Million, 2020-2030Figure 124: Rest-of-the-World ENT Devices Market (by Product Type), $Million, 2020-2030Figure 125: Latin America ENT Devices Market, $Million, 2020-2030Figure 126: Latin America ENT Surgical Devices Market (by End User), $Million, 2020-2030Figure 127: Latin America ENT Diagnostic Devices Market (by End User), $Million, 2020-2030Figure 128: Latin America ENT Devices Market (by Product Type), $Million, 2020-2030Figure 129: Middle East and Africa ENT Devices Market, $Million, 2020-2030Figure 130: Middle East and Africa ENT Surgical Devices Market (by End User), $Million, 2020-2030Figure 131: Middle East and Africa ENT Diagnostic Devices Market (by End User), $Million, 2020-2030Figure 132: Middle East and Africa ENT Devices Market (by Product Type), $Million, 2020-2030Figure 133: Share of Key Developments and Strategies, January 2018-15th November 2021Figure 134: New Offerings Share (by Company), January 2018-15th November 2021Figure 135: Partnerships, Alliances, and Business Expansion Share (by Company), January 2018-15th November 2021Figure 136: Regulatory and Legal Share (by Company), January 2018-15th November 2021Figure 137: Mergers and Acquisitions Share (by Company), January 2018-15th November 2021Figure 138: Funding Activities Share (by Company), January 2018-15th November 2021Figure 139: Ambu A/S: Overall Product PortfolioFigure 140: Ambu A/S: Overall Financials, $Million, 2019-2021Figure 141: Ambu A/S: Revenue (by Business Segment), $Million, 2019-2021Figure 142: Ambu A/S: Revenue (by Region), $Million, 2019-2021Figure 143: Ambu A/S: R&D Expenditure, $Million, 2019-2021Figure 144: Atos Medical Ab: Overall Product PortfolioFigure 145: Atos Medical Ab: Overall Financials, $Million, 2018-2020Figure 146: Atos Medical Ab: Revenue (by Business Segment), $Million, 2018-2020Figure 147: Atos Medical Ab: Revenue (by Region), $Million, 2019-2020Figure 148: Atos Medical Ab: Revenue (by Region), $Million, 2018Figure 149: Atos Medical Ab: R&D Expenditure, $Million, 2018-2020Figure 150: Boston Scientific Corporation: Overall Product PortfolioFigure 151: Boston Scientific Corporation: Overall Financials, $Million, 2018-2020Figure 152: Boston Scientific Corporation: Revenue (by Business Segment), $Million, 2018-2020Figure 153: Boston Scientific Corporation: Revenue (by Region), $Million, 2018-2020Figure 154: Boston Scientific Corporation: R&D Expenditure, $Million, 2018-2020Figure 155: Cochlear Limited: Overall Product PortfolioFigure 156: Cochlear Limited: Overall Financials, $Million, 2019-2021Figure 157: Cochlear Limited: Revenue (by Business Segment), $Million, 2019-2021Figure 158: Cochlear Limited: Revenue (by Region), $Million, 2019-2021Figure 159: Cochlear Limited: R&D Expenditure, $Million, 2019-2021Figure 160: Demant A/S: Overall Product PortfolioFigure 161: Demant A/S: Overall Financials, $Million, 2018-2020Figure 162: Demant A/S: Revenue (by Business Segment), $Million, 2018-2020Figure 163: Demant A/S: Revenue (by Region), $Million, 2018-2020Figure 164: Demant A/S: R&D Expenditure, $Million, 2018-2020Figure 165: Eckert & Ziegler BEBIG AG: Overall Product PortfolioFigure 166: Eckert & Ziegler BEBIG AG:Overall Financials, $Million, 2018-2020Figure 167: Eckert & Ziegler BEBIG AG: Revenue (by Business Segment), $Million, 2018Figure 168: Eckert & Ziegler BEBIG AG: Revenue (by Business Segment), $Million, 2019-2020Figure 169: Eckert & Ziegler BEBIG AG: Revenue (by Region), $Million, 2018-2020Figure 170: Eckert & Ziegler BEBIG AG: R&D Expenditure, $Million, 2018-2020Figure 171: HOYA Corporation: Overall Product PortfolioFigure 172: HOYA Corporation: Overall Financials, $Million, 2019-2021Figure 173: HOYA Corporation: Revenue (by Business Segment), $Million, 2019-2021Figure 174: HOYA Corporation: Revenue (by Region), $Million, 2019-2021Figure 175: HOYA Corporation: R&D Expenditure, $Million, 2019-2021Figure 176: Johnson & Johnson: Overall Product PortfolioFigure 177: Johnson & Johnson: Overall Financials, $Million, 2018-2020Figure 178: Johnson & Johnson: Revenue (by Business Segment), $Million, 2018-2020Figure 179: Johnson & Johnson: Revenue (by Region), $Million, 2018-2020Figure 180: Johnson & Johnson: R&D Expenditure, $Million, 2018-2020Figure 181: KARL STORZ SE & Co. KG: Overall Product PortfolioFigure 182: Medtronic plc: Overall Product PortfolioFigure 183: Medtronic plc: Overall Financials, $Million, 2019-2021Figure 184: Medtronic plc: Revenue (by Business Segment), $Million, 2019-2021Figure 185: Medtronic plc: Revenue (by Region), $Million, 2019-2021Figure 186: Medtronic plc: R&D Expenditure, $Million, 2019-2021Figure 187: Olympus Corporation: Overall Product PortfolioFigure 188: Olympus Corporation: Overall Financials, $Million, 2019-2021Figure 189: Olympus Corporation: Revenue (by Business Segment), $Million, 2020-2021Figure 190: Olympus Corporation: Revenue (by Business Segment), $Million, 2019Figure 191: Olympus Corporation: Revenue (by Region), $Million, 2020-2021Figure 192: Olympus Corporation: Revenue (by Region), $Million, 2019Figure 193: Olympus Corporation: R&D Expenditure, $Million, 2019-2021Figure 194: Richard Wolf GmbH: Overall Product PortfolioFigure 195: Smith & Nephew Plc: Overall Product PortfolioFigure 196: Smith & Nephew Plc: Overall Financials, $Million, 2018-2020Figure 197: Smith & Nephew Plc: Revenue (by Business Segment), $Million, 2018-2020Figure 198: Smith & Nephew Plc: Revenue (by Region), $Million, 2018-2020Figure 199: Smith & Nephew Plc: R&D Expenditure, $Million, 2018-2020Figure 200: Sonova Holding AG: Overall Product PortfolioFigure 201: Sonova Holding AG: Overall Financials, $Million, 2019-2021Figure 202: Sonova Holding AG: Revenue (by Business Segment), $Million, 2019-2021Figure 203: Sonova Holding AG: Revenue (by Region), $Million, 2019-2021Figure 204: Sonova Holding AG: R&D Expenditure, $Million, 2019-2021Figure 205: Stryker Corporation: Overall Product PortfolioFigure 206: Stryker Corporation: Overall Financials, $Million, 2018-2020Figure 207: Stryker Corporation: Revenue (by Business Segment), $Million, 2018-2020Figure 208: Stryker Corporation: Revenue (by Region), $Million, 2018-2020Figure 209: Stryker Corporation: R&D Expenditure, $Million, 2018-2020Figure 210: Global ENT Devices Market, Research MethodologyFigure 211: Primary ResearchFigure 212: Secondary ResearchFigure 213: Data TriangulationFigure 214: Assumptions and LimitationsList of Tables Table 1: Global ENT Devices Market, Impact AnalysisTable 2: Global ENT Devices Market, Inclusion CriteriaTable 3: Global ENT Devices Market, Exclusion CriteriaTable 4: Global ENT Devices Market, Key TrendsTable 5: Global ENT Devices Market, Product BenchmarkingTable 6: Global ENT Devices Market, Ongoing Clinical TrialsTable 7: Global ENT Devices Market, Key Procedure Volumes, 2016-2019Table 8: Comparative Analysis Between Headlight Market and Surgical Loop MarketTable 9: ENT Procedures Share, by Modality, 2019Table 10: Global ENT Devices Market, Impact AnalysisTable 11: FDA Approved/Cleared Advanced ENT Devices, 2019Table 12: North America ENT Devices Market Regulatory FrameworkTable 13: North America ENT Devices Market, Impact AnalysisTable 14: Challenges in MDR ImplementationTable 15: Europe ENT Devices Market, Impact AnalysisTable 16: Asia-Pacific ENT Devices Market Regulatory FrameworkTable 17: Asia-Pacific ENT Devices Market, Impact AnalysisTable 18: Rest-of-the-World ENT Devices Market Regulatory FrameworkTable 19: Rest-of-the-World ENT Devices Market, Impact Analysis